SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001564590-20-054194
Filing Date
2020-11-16
Accepted
2020-11-16 16:33:35
Documents
45
Period of Report
2020-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q Q3 2020 snss-10q_20200930.htm 10-Q 1638181
2 EX-31.1 snss-ex311_6.htm EX-31.1 16728
3 EX-32.1 snss-ex321_8.htm EX-32.1 6758
4 GRAPHIC gqrhbcpv5wao000001.jpg GRAPHIC 3336
  Complete submission text file 0001564590-20-054194.txt   4146732

Data Files

Seq Description Document Type Size
5 XBRL INSTANCE DOCUMENT snss-20200930.xml EX-101.INS 606327
6 XBRL TAXONOMY EXTENSION SCHEMA snss-20200930.xsd EX-101.SCH 34475
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE snss-20200930_cal.xml EX-101.CAL 36337
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE snss-20200930_def.xml EX-101.DEF 92112
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE snss-20200930_lab.xml EX-101.LAB 275838
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE snss-20200930_pre.xml EX-101.PRE 185466
Mailing Address 395 OYSTER POINT BOULEVARD SUITE 400 SOUTH SAN FRANCISCO CA 94080
Business Address 395 OYSTER POINT BOULEVARD SUITE 400 SOUTH SAN FRANCISCO CA 94080 650-266-3500
SUNESIS PHARMACEUTICALS INC (Filer) CIK: 0001061027 (see all company filings)

IRS No.: 943295878 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-51531 | Film No.: 201317608
SIC: 2834 Pharmaceutical Preparations